This article provides an overview of 10 new genetics companies advancing genetic science and its practical applications. These companies offer in vitro fertilization (IVF) genome sequencing, genetic sequencing platforms, AI-based genetic diagnosis tools, and more. This examination highlights the role of these new genetics companies in pushing the boundaries of genetic advancements like RNA editing and gene writing.
Continue reading to gain up-to-date and data-driven insights on:
Click to download
Key Takeaways
Drawing insights from the Big Data & AI-powered StartUs Insights Discovery Platform that provides data on over 4.7+ million emerging companies globally, we explore the evolving landscape of the genetics industry. This sector is marked by key trends and a substantial workforce, shaping its future. This report was last revised 5 days ago. See a missing piece? Your input can help — contact us. Here are some key insights at a glance:
- Current Genetics Trends: The latest genetics trends include next-generation sequencing (NGS), single-cell genomics, gene therapies, and synthetic biology.
- Genetics Market Statistics: The global genetics sector encompasses 44K+ organizations and has a 4 million workforce. It is experiencing an annual growth rate of 4.59% and has seen the emergence of 7K+ new genetics companies in the past five years. Also, the average number of employees stands at 26.
- 10 Top Genetics Companies to Watch:
- Akribion Genomics – Alternative CRISPR Solutions
- GenEmbryomics – IVF Genome Sequencing
- Enigma Genomics – Genetic Sequencing
- Inocras – Whole Genome Sequencing (WGS)
- Solu – Pathogen Surveillance
- Quotient Therapeutics – Somatic Genomics
- Integra Therapeutics – Gene Writing tool
- InEdita Bio – Genome Editing
- gMendel – AI-Based Genetic Diagnosis
- Theranomics – Precision Oncology
Discover 10 out of 7K+ Emerging Genetics Companies
In this section, we spotlight the 10 best genetics companies offering solutions for IVF genome sequencing, AI-based genetic diagnosis, and more. These companies leverage advanced sequencing platforms, AI, and gene editing to enhance precision, diagnostic accuracy, and personalized treatment options. These technologies support embryo selection, mutation detection, targeted therapeutic interventions, and more. Read on to explore the innovative solutions these companies are bringing to the genetics market.
Note on Signal Strength
One of the unique metrics we feature for each company is Signal Strength, a proprietary data point generated by our Discovery Platform. It gauges the extent to which a company’s influence has permeated the global ecosystem of startups, scaleups, and emerging companies. This proprietary metric serves as a valuable guidepost for understanding a company’s standing in the broader market landscape.
1. Akribion Genomics
- Founding Year: 2023
- Employee Range: 11-50
- Location: Germany
- Signal Strength: Very Strong
- What they do: Akribion Genomics develops advanced CRISPR nucleases for genetics-based cancer therapies and genome editing. The company utilizes a proprietary collection of CRISPR nuclease sequences identified through large-scale metagenomic screening. This ensures precision and efficiency in genetic modification. Its G-dase E nuclease is engineered for targeted cell depletion and utilizes an RNA-guided mechanism to enhance efficacy in therapeutic applications. Further, the company’s G-dase M is optimized for high-precision genome editing across organisms. Akribion Genomics’ solutions advance personalized medicine and biotechnological research for novel treatments and cell-based therapies.
2. GenEmbryomics
- Founding Year: 2019
- Employee Range: 11-50
- Location: USA
- Signal Strength: Very Strong
- What they do: GenEmbryomics offers genome sequencing of IVF embryos that provides insights into genetic diseases. The company’s technology, Preimplantation Genetic Testing via Whole Genome Sequencing (PGT-WGS), examines the entire embryo genome rather than focusing on specific genetic markers. This method enhances the detection of potential genetic abnormalities that conventional screening might overlook. By delivering detailed and accurate genetic information, GenEmbryomics allows fertility specialists and prospective parents to make informed decisions, improve IVF success rates, and support the birth of healthier children.
3. Enigma Genomics
- Founding Year: 2022
- Employee Range: 11-50
- Location: Saudi Arabia
- Signal Strength: Medium
- What they do: Enigma Genomics enables advanced genetic sequencing utilizing advanced sequencing and AI to decode genomes and provide personalized health insights. Its platform leverages high-precision AI tools to analyze and interpret extensive genomic data and convert it into actionable knowledge for disease prevention and health optimization. The platform also supports comprehensive genome sequencing and continuous data reanalysis. Enigma Genomics enhances personalized medicine by providing precise, data-driven insights that allow individuals and healthcare providers to make informed decisions about genetic risks and overall well-being.
4. Inocras
- Founding Year: 2020
- Employee Range: 11-50
- Location: USA
- Signal Strength: Very Strong
- What they do: Inocras provides WGS solutions for cancer and rare diseases. Its advanced bioinformatics solutions, CancerVision and RareVision, analyze the genome to identify complex mutations and pathogenic variants missed by conventional testing methods. The company also offers genomic coverage, easy-to-understand reports, and personalized support from genetic counselors. Inocras empowers patients and healthcare providers with actionable genetic insights for more precise diagnoses and tailored treatment plans.
5. Solu
- Founding Year: 2022
- Employee Range: 2-10
- Location: Finland
- Signal Strength: Very Strong
- What they do: Solu offers pathogen surveillance with rapid and cost-effective microbial whole genome sequencing for pathogenic bacteria and fungi. Its technology sequences microbial samples using advanced platforms like Oxford Nanopore and Illumina. This enables precise identification and typing of pathogens, including their antimicrobial resistance genes. The company also offers real-time reporting through a secure, HIPAA-compliant cloud platform for users to access comprehensive data on antimicrobial resistance, plasmid spread, and transmission dynamics. This enables researchers and clinicians to make informed decisions for preventing and controlling infectious diseases efficiently.
6. Quotient Therapeutics
- Founding Year: 2022
- Employee Range: 11-50
- Location: UK
- Signal Strength: Very Strong
- What they do: Quotient Therapeutics creates a somatic genomics platform that identifies extensive variations within the somatic genome. The platform systematically studies the genetic diversity within the trillions of cells in the human body, identifying novel links between genes and diseases. By harnessing this data, it pinpoints naturally selected genetic targets for drug development. This approach enables the discovery of unique therapeutic opportunities for various diseases. Quotient Therapeutics’ platform thus allows pharmaceuticals and healthcare businesses to develop precise, effective treatments.
7. Integra Therapeutics
- Founding Year: 2020
- Employee Range: 2-10
- Location: Spain
- Signal Strength: Very Strong
- What they do: Integra Therapeutics develops FiCAT, a gene writing tool that combines CRISPR-Cas9 technology and PiggyBac transposase to enable precise insertion of DNA fragments. It utilizes a “find” module for targeting and a “cut-and-transfer” module for DNA integration. This addresses challenges of size, precision, and stability in gene therapies. The features of FiCAT include enhanced on-target integration while minimizing off-target effects, making it suitable for both in vivo and ex vivo therapies. Integra Therapeutics advances gene therapies for treating various genetic and oncological diseases.
8. InEdita Bio
- Founding Year: 2022
- Employee Range: 2-10
- Location: Brazil
- Signal Strength: Strong
- What they do: InEdita Bio provides a genome editing platform that modifies the genetic code by altering sequences to develop plants resistant to pests and diseases and improve water and nutrient use efficiency. The platform targets specific genes that enable accurate insertion, deletion, or modification of genetic material to achieve desired plant traits. It enables farmers to enhance crop resilience, reduce dependency on chemical pesticides, and decrease water consumption.
9. gMendel
- Founding Year: 2020
- Employee Range: 11-50
- Location: Denmark
- Signal Strength: Very Strong
- What they do: gMendel develops Phivea, a decision support software for precise diagnosis and real-time prediction of genetic disorders. Phivea automates the diagnostic process, from data analysis to interpretation, eliminating the need for manual intervention by bioinformaticians. This reduces experimental errors and lowers costs. Phivea also integrates into existing healthcare protocols to improve patient outcomes and broaden access to advanced genetic diagnostics.
10. Theranomics
- Founding Year: 2022
- Employee Range: 2-10
- Location: Mexico
- Signal Strength: Weak
- What they do: Theranomics advances precision oncology using innovations in omics sciences. The company’s platform utilizes genomic analysis to develop individualized therapeutic strategies and optimize treatment efficacy by targeting the unique genetic makeup of each patient’s cancer. By integrating genomics, transcriptomics, and proteomics, the platform enhances the precision of diagnosis and treatment selection. This method increases the effectiveness of interventions, particularly in cases where traditional therapies offer limited options.
Quick Tip to Find New Genetics Companies
Utilizing a SaaS platform like the Discovery Platform for identifying new genetics companies provides significant benefits compared to traditional scouting methods:
- Streamlined Efficiency: The Discovery Platform offers advanced tools that streamline the scouting process. It replaces your hours of conventional desk research, saving time and resources in identifying genetics innovations.
- Access to Real-time Insights: Gain a competitive edge with up-to-date information on the latest trends in the genetics industry. The platform keeps you informed with near real-time updates on emerging genetics companies and news, enabling you to make swift and informed decisions.
- Tailored Exploration: Customize your search to focus on specific niches within the genetics sector, such as IVF genome sequencing, genetic sequencing, or AI-based genetic diagnosis. The platform’s diverse filtering options allow you to target your scouting efforts precisely, ensuring that you find the most relevant and groundbreaking companies in the field.
Ready to Explore All New Genetics Companies?
We’ve explored the dynamic landscape of the genetics industry, examining the latest trends and spotlighting exceptional companies driving innovation. To dive deeper, download our free Healthcare Report or schedule a demo of the Discovery Platform for a customized exploration of these groundbreaking developments. We seek partnerships with industry experts to deliver actionable insights into startups and tech. Interested? Let us know!
